Infantile Spasms Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Type ( Monotherapy, Combination Therapy ); Route of Administration ( Oral, Parenteral ); Distribution Channel ( Hospital Pharmacies, Retail Pharmacies, Online Pharmacies ), and Geography
Report Code: TIPRE00015974 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Infantile spasms therapeutics are used to treat seizures or an epilepsy syndrome in young children, usually aged one year or below. Infantile spasm refers to sudden stiffening of the body, the arms, and the legs or forward bending of the head. Primary treatments for infantile spasms include steroid therapy and an anti-seizure medicine called Sabril. The disorder is more common in boys than in girls. The diagnosis of infantile spasms is carried out by physical and neurological examination, laboratory tests such as MRI of the brain, and blood and urine tests.
MARKET DYNAMICS
The increasing prevalence of central nervous system (CNS) infection can develop infantile spasm and rising adoption of infantile spasms treatment procedure will spur the demand for infantile spasms therapeutics market. Additionally, approval from regulatory agencies such as the U.S. Food and Drug Administration (FDA) that helps in speedy approval by designating the orphan drug status to drugs targeted to benefit patients with rare disease expected to boost the market growth to significant extent over the forecast period. However, high cost of treatment, lack of proper diagnosis of infantile spasm, and stringent regulations for drug approval are some the major factor which may restraint the growth of the market in the forecasted period.
MARKET SCOPE
The "Global Infantile Spasms Therapeutics Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of infantile spasms therapeutics market with detailed market segmentation by drug type, roue of administration, distribution channel, and geography. The global infantile spasms therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading infantile spasms therapeutics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global infantile spasms therapeutics market is segmented on the drug type, roue of administration, distribution channel. Based on drug type, the global infantile spasms therapeutics market is segmented into with monotherapy and combination therapy. Based on the route of administration, the infantile spasms therapeutics market is oral, and parenteral. Based on the distribution channel, the infantile spasms therapeutics market is hospital pharmacies, retail pharmacies, online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global infantile spasms therapeutics market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The infantile spasms therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting infantile spasms therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the infantile spasms therapeutics market in these regions.
The reports cover key developments in the infantile spasms therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from infantile spasms therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for infantile spasms therapeutics market in the global market. Below mentioned is the list of few companies engaged in the infantile spasms therapeutics market.
The report also includes the profiles of key infantile spasms therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Infantile spasms therapeutics are used to treat seizures or an epilepsy syndrome in young children, usually aged one year or below. Infantile spasm refers to sudden stiffening of the body, the arms, and the legs or forward bending of the head. Primary treatments for infantile spasms include steroid therapy and an anti-seizure medicine called Sabril. The disorder is more common in boys than in girls. The diagnosis of infantile spasms is carried out by physical and neurological examination, laboratory tests such as MRI of the brain, and blood and urine tests.
MARKET DYNAMICS
The increasing prevalence of central nervous system (CNS) infection can develop infantile spasm and rising adoption of infantile spasms treatment procedure will spur the demand for infantile spasms therapeutics market. Additionally, approval from regulatory agencies such as the U.S. Food and Drug Administration (FDA) that helps in speedy approval by designating the orphan drug status to drugs targeted to benefit patients with rare disease expected to boost the market growth to significant extent over the forecast period. However, high cost of treatment, lack of proper diagnosis of infantile spasm, and stringent regulations for drug approval are some the major factor which may restraint the growth of the market in the forecasted period.
MARKET SCOPE
The "Global Infantile Spasms Therapeutics Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of infantile spasms therapeutics market with detailed market segmentation by drug type, roue of administration, distribution channel, and geography. The global infantile spasms therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading infantile spasms therapeutics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global infantile spasms therapeutics market is segmented on the drug type, roue of administration, distribution channel. Based on drug type, the global infantile spasms therapeutics market is segmented into with monotherapy and combination therapy. Based on the route of administration, the infantile spasms therapeutics market is oral, and parenteral. Based on the distribution channel, the infantile spasms therapeutics market is hospital pharmacies, retail pharmacies, online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global infantile spasms therapeutics market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The infantile spasms therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting infantile spasms therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the infantile spasms therapeutics market in these regions.
The reports cover key developments in the infantile spasms therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from infantile spasms therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for infantile spasms therapeutics market in the global market. Below mentioned is the list of few companies engaged in the infantile spasms therapeutics market.
The report also includes the profiles of key infantile spasms therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- H. Lundbeck A/S
- Mallinckrodt Pharmaceuticals
- Anavex Life Sciences Corp.
- Catalyst Pharmaceuticals
- GW Pharmaceuticals plc
- Retrophin, Inc
- Valerion Therapeutics
- Orphelia Pharma SA
- Insys Therapeutics, Inc.,
- Eve Technologies
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Infantile Spasms Therapeutics Market - By Drug Type
1.3.2 Infantile Spasms Therapeutics Market - By Route of Administration
1.3.3 Infantile Spasms Therapeutics Market - By Distribution Channel
1.3.4 Infantile Spasms Therapeutics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFANTILE SPASMS THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INFANTILE SPASMS THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INFANTILE SPASMS THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. INFANTILE SPASMS THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. INFANTILE SPASMS THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INFANTILE SPASMS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOTHERAPY
7.3.1. Overview
7.3.2. Monotherapy Market Forecast and Analysis
7.3.3. Adrenocorticotropic Hormone Market
7.3.3.1. Overview
7.3.3.2. Adrenocorticotropic Hormone Market Forecast and Analysis
7.3.4. Vigabatrin Market
7.3.4.1. Overview
7.3.4.2. Vigabatrin Market Forecast and Analysis
7.3.5. Others Market
7.3.5.1. Overview
7.3.5.2. Others Market Forecast and Analysis
7.4. COMBINATION THERAPY
7.4.1. Overview
7.4.2. Combination Therapy Market Forecast and Analysis
8. INFANTILE SPASMS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. PARENTERAL
8.4.1. Overview
8.4.2. Parenteral Market Forecast and Analysis
9. INFANTILE SPASMS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. INFANTILE SPASMS THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Infantile Spasms Therapeutics Market Overview
10.1.2 North America Infantile Spasms Therapeutics Market Forecasts and Analysis
10.1.3 North America Infantile Spasms Therapeutics Market Forecasts and Analysis - By Drug Type
10.1.4 North America Infantile Spasms Therapeutics Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Infantile Spasms Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Infantile Spasms Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Infantile Spasms Therapeutics Market
10.1.6.1.1 United States Infantile Spasms Therapeutics Market by Drug Type
10.1.6.1.2 United States Infantile Spasms Therapeutics Market by Route of Administration
10.1.6.1.3 United States Infantile Spasms Therapeutics Market by Distribution Channel
10.1.6.2 Canada Infantile Spasms Therapeutics Market
10.1.6.2.1 Canada Infantile Spasms Therapeutics Market by Drug Type
10.1.6.2.2 Canada Infantile Spasms Therapeutics Market by Route of Administration
10.1.6.2.3 Canada Infantile Spasms Therapeutics Market by Distribution Channel
10.1.6.3 Mexico Infantile Spasms Therapeutics Market
10.1.6.3.1 Mexico Infantile Spasms Therapeutics Market by Drug Type
10.1.6.3.2 Mexico Infantile Spasms Therapeutics Market by Route of Administration
10.1.6.3.3 Mexico Infantile Spasms Therapeutics Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Infantile Spasms Therapeutics Market Overview
10.2.2 Europe Infantile Spasms Therapeutics Market Forecasts and Analysis
10.2.3 Europe Infantile Spasms Therapeutics Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Infantile Spasms Therapeutics Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Infantile Spasms Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Infantile Spasms Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Infantile Spasms Therapeutics Market
10.2.6.1.1 Germany Infantile Spasms Therapeutics Market by Drug Type
10.2.6.1.2 Germany Infantile Spasms Therapeutics Market by Route of Administration
10.2.6.1.3 Germany Infantile Spasms Therapeutics Market by Distribution Channel
10.2.6.2 France Infantile Spasms Therapeutics Market
10.2.6.2.1 France Infantile Spasms Therapeutics Market by Drug Type
10.2.6.2.2 France Infantile Spasms Therapeutics Market by Route of Administration
10.2.6.2.3 France Infantile Spasms Therapeutics Market by Distribution Channel
10.2.6.3 Italy Infantile Spasms Therapeutics Market
10.2.6.3.1 Italy Infantile Spasms Therapeutics Market by Drug Type
10.2.6.3.2 Italy Infantile Spasms Therapeutics Market by Route of Administration
10.2.6.3.3 Italy Infantile Spasms Therapeutics Market by Distribution Channel
10.2.6.4 Spain Infantile Spasms Therapeutics Market
10.2.6.4.1 Spain Infantile Spasms Therapeutics Market by Drug Type
10.2.6.4.2 Spain Infantile Spasms Therapeutics Market by Route of Administration
10.2.6.4.3 Spain Infantile Spasms Therapeutics Market by Distribution Channel
10.2.6.5 United Kingdom Infantile Spasms Therapeutics Market
10.2.6.5.1 United Kingdom Infantile Spasms Therapeutics Market by Drug Type
10.2.6.5.2 United Kingdom Infantile Spasms Therapeutics Market by Route of Administration
10.2.6.5.3 United Kingdom Infantile Spasms Therapeutics Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Infantile Spasms Therapeutics Market Overview
10.3.2 Asia-Pacific Infantile Spasms Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific Infantile Spasms Therapeutics Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Infantile Spasms Therapeutics Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Infantile Spasms Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Infantile Spasms Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Infantile Spasms Therapeutics Market
10.3.6.1.1 Australia Infantile Spasms Therapeutics Market by Drug Type
10.3.6.1.2 Australia Infantile Spasms Therapeutics Market by Route of Administration
10.3.6.1.3 Australia Infantile Spasms Therapeutics Market by Distribution Channel
10.3.6.2 China Infantile Spasms Therapeutics Market
10.3.6.2.1 China Infantile Spasms Therapeutics Market by Drug Type
10.3.6.2.2 China Infantile Spasms Therapeutics Market by Route of Administration
10.3.6.2.3 China Infantile Spasms Therapeutics Market by Distribution Channel
10.3.6.3 India Infantile Spasms Therapeutics Market
10.3.6.3.1 India Infantile Spasms Therapeutics Market by Drug Type
10.3.6.3.2 India Infantile Spasms Therapeutics Market by Route of Administration
10.3.6.3.3 India Infantile Spasms Therapeutics Market by Distribution Channel
10.3.6.4 Japan Infantile Spasms Therapeutics Market
10.3.6.4.1 Japan Infantile Spasms Therapeutics Market by Drug Type
10.3.6.4.2 Japan Infantile Spasms Therapeutics Market by Route of Administration
10.3.6.4.3 Japan Infantile Spasms Therapeutics Market by Distribution Channel
10.3.6.5 South Korea Infantile Spasms Therapeutics Market
10.3.6.5.1 South Korea Infantile Spasms Therapeutics Market by Drug Type
10.3.6.5.2 South Korea Infantile Spasms Therapeutics Market by Route of Administration
10.3.6.5.3 South Korea Infantile Spasms Therapeutics Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Infantile Spasms Therapeutics Market Overview
10.4.2 Middle East and Africa Infantile Spasms Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa Infantile Spasms Therapeutics Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Infantile Spasms Therapeutics Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Infantile Spasms Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Infantile Spasms Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Infantile Spasms Therapeutics Market
10.4.6.1.1 South Africa Infantile Spasms Therapeutics Market by Drug Type
10.4.6.1.2 South Africa Infantile Spasms Therapeutics Market by Route of Administration
10.4.6.1.3 South Africa Infantile Spasms Therapeutics Market by Distribution Channel
10.4.6.2 Saudi Arabia Infantile Spasms Therapeutics Market
10.4.6.2.1 Saudi Arabia Infantile Spasms Therapeutics Market by Drug Type
10.4.6.2.2 Saudi Arabia Infantile Spasms Therapeutics Market by Route of Administration
10.4.6.2.3 Saudi Arabia Infantile Spasms Therapeutics Market by Distribution Channel
10.4.6.3 U.A.E Infantile Spasms Therapeutics Market
10.4.6.3.1 U.A.E Infantile Spasms Therapeutics Market by Drug Type
10.4.6.3.2 U.A.E Infantile Spasms Therapeutics Market by Route of Administration
10.4.6.3.3 U.A.E Infantile Spasms Therapeutics Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Infantile Spasms Therapeutics Market Overview
10.5.2 South and Central America Infantile Spasms Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America Infantile Spasms Therapeutics Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Infantile Spasms Therapeutics Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Infantile Spasms Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Infantile Spasms Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Infantile Spasms Therapeutics Market
10.5.6.1.1 Brazil Infantile Spasms Therapeutics Market by Drug Type
10.5.6.1.2 Brazil Infantile Spasms Therapeutics Market by Route of Administration
10.5.6.1.3 Brazil Infantile Spasms Therapeutics Market by Distribution Channel
10.5.6.2 Argentina Infantile Spasms Therapeutics Market
10.5.6.2.1 Argentina Infantile Spasms Therapeutics Market by Drug Type
10.5.6.2.2 Argentina Infantile Spasms Therapeutics Market by Route of Administration
10.5.6.2.3 Argentina Infantile Spasms Therapeutics Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. INFANTILE SPASMS THERAPEUTICS MARKET, KEY COMPANY PROFILES
13.1. H. LUNDBECK A/S
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. MALLINCKRODT PHARMACEUTICALS
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ANAVEX LIFE SCIENCES CORP.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CATALYST PHARMACEUTICALS
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GW PHARMACEUTICALS PLC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. RETROPHIN, INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. VALERION THERAPEUTICS
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ORPHELIA PHARMA SA
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. INSYS THERAPEUTICS, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. EVE TECHNOLOGIES
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Infantile Spasms Therapeutics Market - By Drug Type
1.3.2 Infantile Spasms Therapeutics Market - By Route of Administration
1.3.3 Infantile Spasms Therapeutics Market - By Distribution Channel
1.3.4 Infantile Spasms Therapeutics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFANTILE SPASMS THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INFANTILE SPASMS THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INFANTILE SPASMS THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. INFANTILE SPASMS THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. INFANTILE SPASMS THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INFANTILE SPASMS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOTHERAPY
7.3.1. Overview
7.3.2. Monotherapy Market Forecast and Analysis
7.3.3. Adrenocorticotropic Hormone Market
7.3.3.1. Overview
7.3.3.2. Adrenocorticotropic Hormone Market Forecast and Analysis
7.3.4. Vigabatrin Market
7.3.4.1. Overview
7.3.4.2. Vigabatrin Market Forecast and Analysis
7.3.5. Others Market
7.3.5.1. Overview
7.3.5.2. Others Market Forecast and Analysis
7.4. COMBINATION THERAPY
7.4.1. Overview
7.4.2. Combination Therapy Market Forecast and Analysis
8. INFANTILE SPASMS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. PARENTERAL
8.4.1. Overview
8.4.2. Parenteral Market Forecast and Analysis
9. INFANTILE SPASMS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. INFANTILE SPASMS THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Infantile Spasms Therapeutics Market Overview
10.1.2 North America Infantile Spasms Therapeutics Market Forecasts and Analysis
10.1.3 North America Infantile Spasms Therapeutics Market Forecasts and Analysis - By Drug Type
10.1.4 North America Infantile Spasms Therapeutics Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Infantile Spasms Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Infantile Spasms Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Infantile Spasms Therapeutics Market
10.1.6.1.1 United States Infantile Spasms Therapeutics Market by Drug Type
10.1.6.1.2 United States Infantile Spasms Therapeutics Market by Route of Administration
10.1.6.1.3 United States Infantile Spasms Therapeutics Market by Distribution Channel
10.1.6.2 Canada Infantile Spasms Therapeutics Market
10.1.6.2.1 Canada Infantile Spasms Therapeutics Market by Drug Type
10.1.6.2.2 Canada Infantile Spasms Therapeutics Market by Route of Administration
10.1.6.2.3 Canada Infantile Spasms Therapeutics Market by Distribution Channel
10.1.6.3 Mexico Infantile Spasms Therapeutics Market
10.1.6.3.1 Mexico Infantile Spasms Therapeutics Market by Drug Type
10.1.6.3.2 Mexico Infantile Spasms Therapeutics Market by Route of Administration
10.1.6.3.3 Mexico Infantile Spasms Therapeutics Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Infantile Spasms Therapeutics Market Overview
10.2.2 Europe Infantile Spasms Therapeutics Market Forecasts and Analysis
10.2.3 Europe Infantile Spasms Therapeutics Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Infantile Spasms Therapeutics Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Infantile Spasms Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Infantile Spasms Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Infantile Spasms Therapeutics Market
10.2.6.1.1 Germany Infantile Spasms Therapeutics Market by Drug Type
10.2.6.1.2 Germany Infantile Spasms Therapeutics Market by Route of Administration
10.2.6.1.3 Germany Infantile Spasms Therapeutics Market by Distribution Channel
10.2.6.2 France Infantile Spasms Therapeutics Market
10.2.6.2.1 France Infantile Spasms Therapeutics Market by Drug Type
10.2.6.2.2 France Infantile Spasms Therapeutics Market by Route of Administration
10.2.6.2.3 France Infantile Spasms Therapeutics Market by Distribution Channel
10.2.6.3 Italy Infantile Spasms Therapeutics Market
10.2.6.3.1 Italy Infantile Spasms Therapeutics Market by Drug Type
10.2.6.3.2 Italy Infantile Spasms Therapeutics Market by Route of Administration
10.2.6.3.3 Italy Infantile Spasms Therapeutics Market by Distribution Channel
10.2.6.4 Spain Infantile Spasms Therapeutics Market
10.2.6.4.1 Spain Infantile Spasms Therapeutics Market by Drug Type
10.2.6.4.2 Spain Infantile Spasms Therapeutics Market by Route of Administration
10.2.6.4.3 Spain Infantile Spasms Therapeutics Market by Distribution Channel
10.2.6.5 United Kingdom Infantile Spasms Therapeutics Market
10.2.6.5.1 United Kingdom Infantile Spasms Therapeutics Market by Drug Type
10.2.6.5.2 United Kingdom Infantile Spasms Therapeutics Market by Route of Administration
10.2.6.5.3 United Kingdom Infantile Spasms Therapeutics Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Infantile Spasms Therapeutics Market Overview
10.3.2 Asia-Pacific Infantile Spasms Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific Infantile Spasms Therapeutics Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Infantile Spasms Therapeutics Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Infantile Spasms Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Infantile Spasms Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Infantile Spasms Therapeutics Market
10.3.6.1.1 Australia Infantile Spasms Therapeutics Market by Drug Type
10.3.6.1.2 Australia Infantile Spasms Therapeutics Market by Route of Administration
10.3.6.1.3 Australia Infantile Spasms Therapeutics Market by Distribution Channel
10.3.6.2 China Infantile Spasms Therapeutics Market
10.3.6.2.1 China Infantile Spasms Therapeutics Market by Drug Type
10.3.6.2.2 China Infantile Spasms Therapeutics Market by Route of Administration
10.3.6.2.3 China Infantile Spasms Therapeutics Market by Distribution Channel
10.3.6.3 India Infantile Spasms Therapeutics Market
10.3.6.3.1 India Infantile Spasms Therapeutics Market by Drug Type
10.3.6.3.2 India Infantile Spasms Therapeutics Market by Route of Administration
10.3.6.3.3 India Infantile Spasms Therapeutics Market by Distribution Channel
10.3.6.4 Japan Infantile Spasms Therapeutics Market
10.3.6.4.1 Japan Infantile Spasms Therapeutics Market by Drug Type
10.3.6.4.2 Japan Infantile Spasms Therapeutics Market by Route of Administration
10.3.6.4.3 Japan Infantile Spasms Therapeutics Market by Distribution Channel
10.3.6.5 South Korea Infantile Spasms Therapeutics Market
10.3.6.5.1 South Korea Infantile Spasms Therapeutics Market by Drug Type
10.3.6.5.2 South Korea Infantile Spasms Therapeutics Market by Route of Administration
10.3.6.5.3 South Korea Infantile Spasms Therapeutics Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Infantile Spasms Therapeutics Market Overview
10.4.2 Middle East and Africa Infantile Spasms Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa Infantile Spasms Therapeutics Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Infantile Spasms Therapeutics Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Infantile Spasms Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Infantile Spasms Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Infantile Spasms Therapeutics Market
10.4.6.1.1 South Africa Infantile Spasms Therapeutics Market by Drug Type
10.4.6.1.2 South Africa Infantile Spasms Therapeutics Market by Route of Administration
10.4.6.1.3 South Africa Infantile Spasms Therapeutics Market by Distribution Channel
10.4.6.2 Saudi Arabia Infantile Spasms Therapeutics Market
10.4.6.2.1 Saudi Arabia Infantile Spasms Therapeutics Market by Drug Type
10.4.6.2.2 Saudi Arabia Infantile Spasms Therapeutics Market by Route of Administration
10.4.6.2.3 Saudi Arabia Infantile Spasms Therapeutics Market by Distribution Channel
10.4.6.3 U.A.E Infantile Spasms Therapeutics Market
10.4.6.3.1 U.A.E Infantile Spasms Therapeutics Market by Drug Type
10.4.6.3.2 U.A.E Infantile Spasms Therapeutics Market by Route of Administration
10.4.6.3.3 U.A.E Infantile Spasms Therapeutics Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Infantile Spasms Therapeutics Market Overview
10.5.2 South and Central America Infantile Spasms Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America Infantile Spasms Therapeutics Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Infantile Spasms Therapeutics Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Infantile Spasms Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Infantile Spasms Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Infantile Spasms Therapeutics Market
10.5.6.1.1 Brazil Infantile Spasms Therapeutics Market by Drug Type
10.5.6.1.2 Brazil Infantile Spasms Therapeutics Market by Route of Administration
10.5.6.1.3 Brazil Infantile Spasms Therapeutics Market by Distribution Channel
10.5.6.2 Argentina Infantile Spasms Therapeutics Market
10.5.6.2.1 Argentina Infantile Spasms Therapeutics Market by Drug Type
10.5.6.2.2 Argentina Infantile Spasms Therapeutics Market by Route of Administration
10.5.6.2.3 Argentina Infantile Spasms Therapeutics Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. INFANTILE SPASMS THERAPEUTICS MARKET, KEY COMPANY PROFILES
13.1. H. LUNDBECK A/S
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. MALLINCKRODT PHARMACEUTICALS
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ANAVEX LIFE SCIENCES CORP.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CATALYST PHARMACEUTICALS
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GW PHARMACEUTICALS PLC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. RETROPHIN, INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. VALERION THERAPEUTICS
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ORPHELIA PHARMA SA
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. INSYS THERAPEUTICS, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. EVE TECHNOLOGIES
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. H. Lundbeck A/S
2. Mallinckrodt Pharmaceuticals
3. Anavex Life Sciences Corp.
4. Catalyst Pharmaceuticals
5. GW Pharmaceuticals plc
6. Retrophin, Inc
7. Valerion Therapeutics
8. Orphelia Pharma SA
9. Insys Therapeutics, Inc.,
10. Eve Technologies
1. H. Lundbeck A/S
2. Mallinckrodt Pharmaceuticals
3. Anavex Life Sciences Corp.
4. Catalyst Pharmaceuticals
5. GW Pharmaceuticals plc
6. Retrophin, Inc
7. Valerion Therapeutics
8. Orphelia Pharma SA
9. Insys Therapeutics, Inc.,
10. Eve Technologies